サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1537079

リアルタイムPCR（qPCR）市場：世界の産業分析、規模、シェア、成長、動向、2024-2033年予測

Real Time Pcr Qpcr Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 204 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
リアルタイムPCR（qPCR）市場：世界の産業分析、規模、シェア、成長、動向、2024-2033年予測
出版日: 2024年08月15日
発行: Persistence Market Research
ページ情報: 英文 204 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、世界のリアルタイムPCR（qPCR）市場に関する包括的なレポートを発表しました。当レポートでは、市場促進要因・動向・機会・課題を含む重要な市場ダイナミクスを詳細に評価し、市場構造に関する詳細な洞察を提供しています。

主要な洞察

  • リアルタイムPCR（qPCR）市場規模（2024E）：39億8,000万米ドル
  • 予測市場規模（2033F）：78億米ドル
  • 世界市場成長率（CAGR 2024年から2033年まで）：7.7%

リアルタイムPCR（qPCR）市場- 調査範囲：

リアルタイムPCR（qPCR）技術は、遺伝子発現解析、遺伝子変異研究、病原体検出など、様々な科学的応用において重要な役割を果たしています。この技術は、リアルタイムで核酸の正確かつ定量的な測定を可能にし、高感度、特異性、効率性などの利点を提供します。リアルタイムPCR（qPCR）市場は、研究機関、診断ラボ、病院、バイオテクノロジー企業などを対象に、さまざまな装置、試薬、消耗品を提供しています。

市場促進要因：

世界のリアルタイムPCR（qPCR）市場は、正確な診断ツールを必要とする感染症や遺伝性疾患の流行の増加など、いくつかの重要な要因によって牽引されています。個別化医療への需要の高まりと分子生物学研究の進歩が市場拡大をさらに後押しします。マルチプレックスqPCRアッセイの開発やサーマルサイクラーの改良などの技術革新は、Real-Time PCR技術の機能と応用を強化しています。さらに、研究活動の拡大とゲノミクスおよびプロテオミクス研究のための資金調達が、さまざまな分野でのqPCR技術の採用拡大に寄与しています。

市場抑制要因：

その有望な成長にもかかわらず、リアルタイムPCR（qPCR）市場は、高度な機器や試薬に関連する高コストに関する課題に直面しています。また、qPCR技術の複雑さや専門的なトレーニングの必要性も、特に発展途上地域における導入の障壁となる可能性があります。さらに、診断アッセイの承認に関する厳しい規制要件や、機器の継続的なバリデーションとキャリブレーションの必要性も、市場力学に影響を与える可能性があります。これらの課題に対処するには、継続的な技術革新、コスト削減戦略、トレーニングや教育への支援強化が必要です。

市場機会：

リアルタイムPCR（qPCR）市場は、技術の進歩、研究・診断アプリケーションの増加、ヘルスケアニーズの拡大により、大きな成長機会がもたらされます。qPCRと次世代シーケンシング（NGS）などの他の分子技術との統合は、研究や臨床診断に新たな道を提供します。感染症の発生やがん診断への注目の高まりは、革新的なソリューションを開発する市場プレーヤーに大きなチャンスをもたらします。戦略的パートナーシップ、研究開発への投資、費用対効果の高いqPCRソリューションのイントロダクションは、新たなビジネスチャンスを生かし、市場でのリーダーシップを維持するために不可欠です。

本レポートで扱う主な質問

  • リアルタイムPCR（qPCR）市場の世界の成長を促進する主な要因は何か？
  • どのqPCR技術とアプリケーションが研究および臨床の現場で支持を集めているか？
  • 技術の進歩はリアルタイムPCR（qPCR）市場の競合情勢にどのような影響を与えているのか？
  • リアルタイムPCR（qPCR）市場に貢献している主要プレイヤーは誰で、市場の関連性を維持するためにどのような戦略を採用しているのか？
  • 世界のリアルタイムPCR（qPCR）市場の新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 重要成功要因

  • 採用率/使用状況分析- 地域別
  • パイプライン評価
  • 規制シナリオ
  • 技術評価
  • PESTEL分析
  • ポーターの分析
  • バリューチェーン分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 製品別
    • アプリケーション別
    • エンドユーザー別
    • 地域別
  • 2024年の市場シナリオ

第7章 世界市場の需要（金額）分析

  • 市場（金額）分析、2019～2023年
  • 市場（金額）分析と予測、2024～2033年
    • 前年比成長動向分析
    • 絶対的収益機会

第8章 製品別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • リアルタイムPCR（qPCR）システム
    • 試薬とアッセイ
    • リアルタイムPCR（qPCR）消耗品
      • PCRプライマー、アッセイ、アレイ
      • PCRプレート、シール、チューブ
  • 製品別市場の魅力分析

第9章 アプリケーション別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • 臨床
    • 調査
    • 法医学その他
  • アプリケーション別の市場の魅力分析

第10章 エンドユーザー別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • 病院
    • 診断検査室
    • 学術調査機関
    • バイオ医薬品企業
    • 契約調査機関
    • 動物の健康
    • 食品・農業産業
  • エンドユーザー別市場の魅力分析

第11章 地域別：世界市場分析

  • イントロダクション
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東およびアフリカ
  • 地域別市場の魅力分析

第12章 北米市場分析

第13章 ラテンアメリカ市場分析

第14章 欧州市場分析

第15章 東アジア市場分析

第16章 南アジア市場分析

第17章 オセアニア市場

第18章 中東・アフリカ市場分析

第19章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第20章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Medtronic plc
    • St. Jude Medical Inc.
    • Boston Scientific Corporation
    • Abbott
    • Cyberonic, Inc.
    • Qiagen
    • Bio-Rad Laboratories Inc.
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific, Inc.
    • GE Healthcare
    • BIOMERIEUX
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Fluidigm Corporation

第21章 使用される前提条件と頭字語

第22章 調査手法

目次
Product Code: PMRREP31513

Persistence Market Research has recently released a comprehensive report on the global Real-Time PCR (qPCR) market. This report provides an in-depth evaluation of crucial market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.

Key Insights:

  • Real-Time PCR (qPCR) Market Size (2024E): USD 3.98 Billion
  • Projected Market Value (2033F): USD 7.8 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 7.7%

Real-Time PCR (qPCR) Market - Report Scope:

Real-Time PCR (qPCR) technology plays a crucial role in various scientific applications, including gene expression analysis, genetic variation studies, and pathogen detection. This technology enables accurate and quantitative measurement of nucleic acids in real time, offering advantages such as high sensitivity, specificity, and efficiency. The Real-Time PCR (qPCR) market caters to research institutions, diagnostic laboratories, hospitals, and biotechnology companies, providing a range of instruments, reagents, and consumables.

Market Growth Drivers:

The global Real-Time PCR (qPCR) market is driven by several key factors, including the increasing prevalence of infectious diseases and genetic disorders, which necessitate precise diagnostic tools. The growing demand for personalized medicine and advancements in molecular biology research further propel market expansion. Technological innovations, such as the development of multiplex qPCR assays and improvements in thermal cyclers, enhance the capabilities and applications of Real-Time PCR technology. Moreover, the expansion of research activities and funding for genomics and proteomics research contribute to the growing adoption of qPCR technology across various sectors.

Market Restraints:

Despite its promising growth, the Real-Time PCR (qPCR) market faces challenges related to high costs associated with advanced instruments and reagents. The complexity of qPCR technology and the need for specialized training can also pose barriers to adoption, particularly in developing regions. Additionally, the stringent regulatory requirements for the approval of diagnostic assays and the need for continuous validation and calibration of instruments may impact market dynamics. Addressing these challenges requires ongoing innovation, cost reduction strategies, and enhanced support for training and education.

Market Opportunities:

The Real-Time PCR (qPCR) market presents significant growth opportunities driven by advancements in technology, increasing research and diagnostic applications, and expanding healthcare needs. The integration of qPCR with other molecular techniques, such as next-generation sequencing (NGS), offers new avenues for research and clinical diagnostics. The growing focus on infectious disease outbreaks and cancer diagnostics creates substantial opportunities for market players to develop innovative solutions. Strategic partnerships, investments in R&D, and the introduction of cost-effective qPCR solutions are essential to capitalize on emerging opportunities and sustain market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Real-Time PCR (qPCR) market globally?
  • Which qPCR technologies and applications are gaining traction in research and clinical settings?
  • How are technological advancements influencing the competitive landscape of the Real-Time PCR (qPCR) market?
  • Who are the key players contributing to the Real-Time PCR (qPCR) market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global Real-Time PCR (qPCR) market?

Competitive Intelligence and Business Strategy:

Leading players in the global Real-Time PCR (qPCR) market, including Thermo Fisher Scientific, Bio-Rad Laboratories, and Roche Diagnostics, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced qPCR platforms, reagents, and consumables, catering to diverse research and diagnostic needs. Collaborations with academic institutions, research organizations, and healthcare providers facilitate market access and promote technology adoption. Emphasis on product development, regulatory compliance, and customer support drives market growth and enhances competitive positioning in the rapidly evolving Real-Time PCR landscape.

Key Companies Profiled:

  • Medtronic plc
  • St. Jude Medical Inc.
  • Boston Scientific Corporation
  • Abbott
  • Cyberonic, Inc.
  • Qiagen
  • Bio-Rad Laboratories Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • GE Healthcare
  • BIOMERIEUX
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fluidigm Corporation

Key Segments Covered in Real time PCR qPCR Industry Research

Product:

  • Real-Time PCR (qPCR) Systems
  • Reagents and Assays
  • Real-Time PCR (qPCR) Consumables

Application:

  • Clinical
  • Research
  • Forensic and Others

End User:

  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Animal Health
  • Food & Agriculture Industries

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Adoption Rate/Usage Analysis - By Region
  • 4.2. Pipeline Assessment
  • 4.3. Regulatory Scenario
  • 4.4. Technology Assessment
  • 4.5. PESTEL Analysis
  • 4.6. Porter's Analysis
  • 4.7. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Polymerase Chain Reaction Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Prevalence of Chronic and Infectious Diseases
    • 5.2.2. Rising Adoption of Scientific Sciences
    • 5.2.3. Growing Use of PCR Techniques
    • 5.2.4. Expanding Biopharmaceutical and Biotechnology Industries
    • 5.2.5. Increased Disease Diagnosis
    • 5.2.6. Efforts in Discovering Novel Drugs
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Application
    • 6.1.3. By End User
    • 6.1.4. By Region
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis, by Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Product, 2024-2033
    • 8.3.1. Real-Time PCR (qPCR) Systems
    • 8.3.2. Reagents and Assays
    • 8.3.3. Real-Time PCR (qPCR) Consumables
      • 8.3.3.1. PCR Primers, Assays, and Arrays
      • 8.3.3.2. PCR Plates, Seals & Tubes
  • 8.4. Market Attractiveness Analysis, by Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Application, 2024-2033
    • 9.3.1. Clinical
    • 9.3.2. Research
    • 9.3.3. Forensic and Others
  • 9.4. Market Attractiveness Analysis, by Application

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by End User, 2024-2033
    • 10.3.1. Hospitals
    • 10.3.2. Diagnostic Laboratories
    • 10.3.3. Academic and Research Institutes
    • 10.3.4. Biopharmaceutical Companies
    • 10.3.5. Contract Research Organizations
    • 10.3.6. Animal Health
    • 10.3.7. Food & Agriculture Industries
  • 10.4. Market Attractiveness Analysis, by End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) Analysis, by Region, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis, by Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Product
    • 12.3.3. By Application
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By Application
    • 12.4.4. By End User
  • 12.5. Market Trends
  • 12.6. Key Market Participants - Intensity Mapping
  • 12.7. Drivers and Restraints - Impact Analysis
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. U.S. Market Analysis
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.8.1.2.1. By Product
        • 12.8.1.2.2. By Application
        • 12.8.1.2.3. By End User
    • 12.8.2. Canada Market Analysis
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.8.2.2.1. By Product
        • 12.8.2.2.2. By Application
        • 12.8.2.2.3. By End User

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Mexico
      • 13.3.1.2. Brazil
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Product
    • 13.3.3. By Application
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Application
    • 13.4.4. By End User
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Mexico Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By Application
        • 13.8.1.2.3. By End User
    • 13.8.2. Brazil Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By Application
        • 13.8.2.2.3. By End User
    • 13.8.3. Argentina Market Analysis
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.8.3.2.1. By Product
        • 13.8.3.2.2. By Application
        • 13.8.3.2.3. By End User

14. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Product
    • 14.3.3. By Application
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Application
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Germany Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Application
        • 14.8.1.2.3. By End User
    • 14.8.2. Italy Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Application
        • 14.8.2.2.3. By End User
    • 14.8.3. France Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By Application
        • 14.8.3.2.3. By End User
    • 14.8.4. U.K. Market Analysis
      • 14.8.4.1. Introduction
      • 14.8.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.4.2.1. By Product
        • 14.8.4.2.2. By Application
        • 14.8.4.2.3. By End User
    • 14.8.5. Spain Market Analysis
      • 14.8.5.1. Introduction
      • 14.8.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.5.2.1. By Product
        • 14.8.5.2.2. By Application
        • 14.8.5.2.3. By End User
    • 14.8.6. BENELUX Market Analysis
      • 14.8.6.1. Introduction
      • 14.8.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.6.2.1. By Product
        • 14.8.6.2.2. By Application
        • 14.8.6.2.3. By End User
    • 14.8.7. Russia Market Analysis
      • 14.8.7.1. Introduction
      • 14.8.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.7.2.1. By Product
        • 14.8.7.2.2. By Application
        • 14.8.7.2.3. By End User

15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Product
    • 15.3.3. By Application
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Product
    • 15.4.2. By Application
    • 15.4.3. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. China Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Application
        • 15.8.1.2.3. By End User
    • 15.8.2. Japan Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Application
        • 15.8.2.2.3. By End User
    • 15.8.3. South Korea Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Application
        • 15.8.3.2.3. By End User

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Product
    • 16.3.3. By Application
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Application
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. India Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Application
        • 16.8.1.2.3. By End User
    • 16.8.2. Indonesia Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Application
        • 16.8.2.2.3. By End User
    • 16.8.3. Malaysia Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Application
        • 16.8.3.2.3. By End User
    • 16.8.4. Thailand Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Application
        • 16.8.4.2.3. By End User

17. Oceania Market 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Product
    • 17.3.3. By Application
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Application
    • 17.4.4. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. Australia Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Application
        • 17.8.1.2.3. By End User
    • 17.8.2. New Zealand Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Application
        • 17.8.2.2.3. By End User

18. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkiye
      • 18.3.1.3. South Africa
      • 18.3.1.4. North Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Product
    • 18.3.3. By Application
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Product
    • 18.4.2. By Application
    • 18.4.3. By End User
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. GCC Countries Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Application
        • 18.8.1.2.3. By End User
    • 18.8.2. Turkiye Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Application
        • 18.8.2.2.3. By End User
    • 18.8.3. South Africa Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Application
        • 18.8.3.2.3. By End User
    • 18.8.4. North Africa Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.4.2.1. By Product
        • 18.8.4.2.2. By Application
        • 18.8.4.2.3. By End User

19. Market Structure Analysis

  • 19.1. Market Analysis, by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Medtronic plc
      • 20.3.1.1. Overview
      • 20.3.1.2. Product Portfolio
      • 20.3.1.3. Sales Footprint
      • 20.3.1.4. Key Financials
      • 20.3.1.5. SWOT Analysis
      • 20.3.1.6. Strategy Overview
        • 20.3.1.6.1. Marketing Strategy
        • 20.3.1.6.2. Product Strategy
        • 20.3.1.6.3. Channel Strategy
    • 20.3.2. St. Jude Medical Inc.
      • 20.3.2.1. Overview
      • 20.3.2.2. Product Portfolio
      • 20.3.2.3. Sales Footprint
      • 20.3.2.4. Key Financials
      • 20.3.2.5. SWOT Analysis
      • 20.3.2.6. Strategy Overview
        • 20.3.2.6.1. Marketing Strategy
        • 20.3.2.6.2. Product Strategy
        • 20.3.2.6.3. Channel Strategy
    • 20.3.3. Boston Scientific Corporation
      • 20.3.3.1. Overview
      • 20.3.3.2. Product Portfolio
      • 20.3.3.3. Sales Footprint
      • 20.3.3.4. Key Financials
      • 20.3.3.5. SWOT Analysis
      • 20.3.3.6. Strategy Overview
        • 20.3.3.6.1. Marketing Strategy
        • 20.3.3.6.2. Product Strategy
        • 20.3.3.6.3. Channel Strategy
    • 20.3.4. Abbott
      • 20.3.4.1. Overview
      • 20.3.4.2. Product Portfolio
      • 20.3.4.3. Sales Footprint
      • 20.3.4.4. Key Financials
      • 20.3.4.5. SWOT Analysis
      • 20.3.4.6. Strategy Overview
        • 20.3.4.6.1. Marketing Strategy
        • 20.3.4.6.2. Product Strategy
        • 20.3.4.6.3. Channel Strategy
    • 20.3.5. Cyberonic, Inc.
      • 20.3.5.1. Overview
      • 20.3.5.2. Product Portfolio
      • 20.3.5.3. Sales Footprint
      • 20.3.5.4. Key Financials
      • 20.3.5.5. SWOT Analysis
      • 20.3.5.6. Strategy Overview
        • 20.3.5.6.1. Marketing Strategy
        • 20.3.5.6.2. Product Strategy
        • 20.3.5.6.3. Channel Strategy
    • 20.3.6. Qiagen
      • 20.3.6.1. Overview
      • 20.3.6.2. Product Portfolio
      • 20.3.6.3. Sales Footprint
      • 20.3.6.4. Key Financials
      • 20.3.6.5. SWOT Analysis
      • 20.3.6.6. Strategy Overview
        • 20.3.6.6.1. Marketing Strategy
        • 20.3.6.6.2. Product Strategy
        • 20.3.6.6.3. Channel Strategy
    • 20.3.7. Bio-Rad Laboratories Inc.
      • 20.3.7.1. Overview
      • 20.3.7.2. Product Portfolio
      • 20.3.7.3. Sales Footprint
      • 20.3.7.4. Key Financials
      • 20.3.7.5. SWOT Analysis
      • 20.3.7.6. Strategy Overview
        • 20.3.7.6.1. Marketing Strategy
        • 20.3.7.6.2. Product Strategy
        • 20.3.7.6.3. Channel Strategy
    • 20.3.8. Agilent Technologies, Inc.
      • 20.3.8.1. Overview
      • 20.3.8.2. Product Portfolio
      • 20.3.8.3. Sales Footprint
      • 20.3.8.4. Key Financials
      • 20.3.8.5. SWOT Analysis
      • 20.3.8.6. Strategy Overview
        • 20.3.8.6.1. Marketing Strategy
        • 20.3.8.6.2. Product Strategy
        • 20.3.8.6.3. Channel Strategy
    • 20.3.9. Thermo Fisher Scientific, Inc.
      • 20.3.9.1. Overview
      • 20.3.9.2. Product Portfolio
      • 20.3.9.3. Sales Footprint
      • 20.3.9.4. Key Financials
      • 20.3.9.5. SWOT Analysis
      • 20.3.9.6. Strategy Overview
        • 20.3.9.6.1. Marketing Strategy
        • 20.3.9.6.2. Product Strategy
        • 20.3.9.6.3. Channel Strategy
    • 20.3.10. GE Healthcare
      • 20.3.10.1. Overview
      • 20.3.10.2. Product Portfolio
      • 20.3.10.3. Sales Footprint
      • 20.3.10.4. Key Financials
      • 20.3.10.5. SWOT Analysis
      • 20.3.10.6. Strategy Overview
        • 20.3.10.6.1. Marketing Strategy
        • 20.3.10.6.2. Product Strategy
        • 20.3.10.6.3. Channel Strategy
    • 20.3.11. BIOMERIEUX
      • 20.3.11.1. Overview
      • 20.3.11.2. Product Portfolio
      • 20.3.11.3. Sales Footprint
      • 20.3.11.4. Key Financials
      • 20.3.11.5. SWOT Analysis
      • 20.3.11.6. Strategy Overview
        • 20.3.11.6.1. Marketing Strategy
        • 20.3.11.6.2. Product Strategy
        • 20.3.11.6.3. Channel Strategy
    • 20.3.12. Bio-Rad Laboratories, Inc.
      • 20.3.12.1. Overview
      • 20.3.12.2. Product Portfolio
      • 20.3.12.3. Sales Footprint
      • 20.3.12.4. Key Financials
      • 20.3.12.5. SWOT Analysis
      • 20.3.12.6. Strategy Overview
        • 20.3.12.6.1. Marketing Strategy
        • 20.3.12.6.2. Product Strategy
        • 20.3.12.6.3. Channel Strategy
    • 20.3.13. F. Hoffmann-La Roche Ltd.
      • 20.3.13.1. Overview
      • 20.3.13.2. Product Portfolio
      • 20.3.13.3. Sales Footprint
      • 20.3.13.4. Key Financials
      • 20.3.13.5. SWOT Analysis
      • 20.3.13.6. Strategy Overview
        • 20.3.13.6.1. Marketing Strategy
        • 20.3.13.6.2. Product Strategy
        • 20.3.13.6.3. Channel Strategy
    • 20.3.14. Fluidigm Corporation
      • 20.3.14.1. Overview
      • 20.3.14.2. Product Portfolio
      • 20.3.14.3. Sales Footprint
      • 20.3.14.4. Key Financials
      • 20.3.14.5. SWOT Analysis
      • 20.3.14.6. Strategy Overview
        • 20.3.14.6.1. Marketing Strategy
        • 20.3.14.6.2. Product Strategy
        • 20.3.14.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology